LifeScience
New distribution center officially opened in Enfield, Connecticut Targeted strengthening of the supply chain and of the customer focus throughout the Am...
May 11, 2023 | News
-Boehringer Ingelheim announced that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 stu...
May 11, 2023 | News
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...
May 10, 2023 | News
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...
May 09, 2023 | News
HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...
May 09, 2023 | News
The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...
May 09, 2023 | Opinion
The global headquarters of Duoning biotech is located in the heart of the Biotechnology Park, with a total construction area of over 40,000m2, includi...
May 08, 2023 | News
Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-...
May 05, 2023 | News
MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daej...
May 03, 2023 | News
Pall Life Sciences and Cytiva have united under the Cytiva name — forming an even stronger global provider of technologies and services that advanc...
May 02, 2023 | News
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...
May 01, 2023 | News
"This agreement signed by OBiO and CHINAGENE is a continuation and sublimation from previous cooperation," Guodong Jia, CEO of OBiO said, "CHINAGENE i...
April 30, 2023 | News
Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...
April 26, 2023 | News
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
April 26, 2023 | News
Most Read
Bio Jobs
News